1Nicol AF, Nuovo GJ, Dillner J. A summary of the 25th International Papillomavirus Conference 2009: Vaccines, screening, epidemiology and therapeutics [J]. J Clin Viral, 2010,47 (3) : 208-215.
2Trottier H, Burchell AN. Epidemiology of mucosal human papillomavirus infection and associated diseases [J]. Public Health Genomics, 2009,12 (5-6) : 291-307.
3Kumaraswamy KL, Vidhya M. Human papilloma virus and oral infections: an update[J]. J Cancer Res Ther, 2011,7 (2) : 120-127.
4Feller L, Khammissa RA, Wood NH, et al. Epithelial maturation and molecular biology of oral HPV [J]. Infect Agent Cancer, 2009,4: 16.
5de Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses [J']. Virology, 2004, 324 (1) : 17-27.
6Syrjanen S. Human papillomavirus infection and its association with HIV [J]. Adv Dent Res, 2011,23 (1) : 84-89.
7Rautava J,Syrjanen S. Human papillomavirus infections in the oral mueosa[J]. J Am Dent Assoc, 2011,142 (8) : 905-914.
8Lacour DE,Trimble C. Human papillomavirus in infants:transmis- sion,prevalence, and persistence [J]. J Pediatr Adolesc Gynecol, 2012, 25 (2) : 93-97.
9Sugerman P, Shillitoe E. The high risk human papillomaviruses and oral cancer: evidence for and against a causal relationship [J]. Oral Dis, 1997,3(3): 130-147.
10Sanders AE, Slade GD, Patton LL. National prevalence of oral HPV infection and related risk factors in the US adult population [J]. Oral Dis,2012, 18:430-441.
